Company Profile

Nasus Medical Inc (AKA: Entera Therapeutics)
Profile last edited on: 11/10/2022      CAGE: 8FC49      UEI: MH2MEDQ7ZSU5

Business Identifier: Intranasal drug delivery device: rherapeutic areas: Chronic Sinusitis and other disease states
Year Founded
2019
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

245 West 2nd Street
Mesa, AZ 85201
   (516) 978-0179
   N/A
   www.nasusmedical.com
Location: Single
Congr. District: 09
County: Maricopa

Public Profile

Formerly dba Entera Therapeutics - Nasus Medical Inc is based in Mesa AZ with facilities also in Mountain View CA. Principals of the firm with background experience in drug delivery and in surgical devices are currently structured around development of a non-invasive drug-delivery device designed to support ENT treatments. Principals of the firm are tackling the problem of insufficient early treatment for Chronic Sinusitis by employing the principles of collaborative thinking, human centered design, and value creation in healthcare, along with our expertise in clinical ENT, early product design, and technology commercialization. What the firm has in development is designed to enable patients to manage their disease in a non-clinical setting without significant side effects or invasive procedures with the Nasus medical device including systemic drugs or surgical procedures for chronic rhinosinusitis diseases,

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $255,977
Project Title: Development of a Novel Miniature Spray Mechanism for Nasal Drug Delivery

Key People / Management

  Shira Koss -- Chief Executive Officer

  Adam Gold -- Co-Founder & Chief Technology Officer

Company News

There are no news available.